Ovarian cancer: Current management and future directions

Obstetrics, Gynaecology and Reproductive Medicine

Volumn 22, Issue 2, 2012, Pages 33-37

  Taylor, Siân E ^a   Kirwan, John M ^a  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Ovarian cancer; Screening; Surgery

Indexed keywords

AROMATASE INHIBITOR; BLEOMYCIN; CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; TAMOXIFEN; TOPOTECAN;

ARTICLE; BORDERLINE OVARIAN TUMOR; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CHEMOSENSITIVITY; CHORIOCARCINOMA; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; DYSGERMINOMA; EPITHELIAL OVARIAN CANCER; GENETIC PREDISPOSITION; HUMAN; MALIGNANT GERM CELL TUMOR; MULTIPLE CYCLE TREATMENT; OVARY CANCER; OVARY TERATOMA; PERITONEUM CANCER; PROGNOSIS; SEX CORD STROMAL TUMOR; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; YOLK SAC TUMOR;

EID: 84855968786     PISSN: 17517214     EISSN: 18793622     Source Type: Journal    
DOI: 10.1016/j.ogrm.2011.11.003     Document Type: Article

References (11)

1. Agarwal R., Linch M., Kaye S.B. Novel therapeutic agents in ovarian cancer. EJSO 2006, 32:875-886.
2. Aletti G.D., Gallenberg M.M., Cliby W.A., Jatoi A.J., Hartmann L.C. Current management strategies for ovarian cancer. Mayo Clin Proc 2007, 82:751-770.
3. Blagden S., Gabra H. Future directions in the management of epithelial ovarian cancer. Future Oncol 2008, 4:403-411.
4. Cannistra S.A. Cancer of the ovary. N Engl J Med 2004, 351:2519-2529.
5. Colombo N., Parma G., Zanagnolo V., Insinga A. Management of ovarian stromal cell tumours. J Clin Oncol 2007, 25:2944-2951.
6. Gershenson D.M. Management of ovarian germ cell tumours. J Clin Oncol 2007, 25:2938-2943.
7. Goff B.A., Mandel L., Muntz H.G., Melancon C.H. Ovarian carcinoma diagnosis, results of a national ovarian cancer survey. Cancer 2000, 89:2068-2075.
8. Markman M. New, expanded, and modified use of approved antineoplastic agents in ovarian cancer. The Oncologist 2007, 12:186-190.
9. NICE clinical guideline 122, Ovarian Cancer.
10. Nickles Fader A., Rose P.G. Role of surgery in ovarian carcinoma. J Clin Oncol 2007, 25:2873-2883.
11. Rao G., Crispens M., Rothenberg M.L. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective. J Clin Oncol 2007, 25:2867-2872.